🇺🇸 FDA
Pipeline program

AG-120/S95031 250mg film-coated tablet, Ivosidenib-matched Placebo Tablets

CL3-95031-007

Phase 3 small_molecule active

Quick answer

AG-120/S95031 250mg film-coated tablet, Ivosidenib-matched Placebo Tablets for Locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 or 2 systemic treatment regimens is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 or 2 systemic treatment regimens
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials